---
$id: https://graph.org.ai/products/commodity/51142568
$type: Product
source: UNSPSC
code: "51142568"
title: "Rasagiline mesilate or mesylate"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rasagiline mesilate or mesylate

**UNSPSC Code**: 51142568
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula C12H13N.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LH8C2JI290, chemically known as 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-, (r)-, methanesulfonate but more generally known as rasagiline mesilate, which bears US NIH Compound Identifier 3052775. European Medicines Agency schedules Rasagiline mesilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21334. Most nations, for tariff and trade purposes, schedule rasagiline mesylate under HS 29214980 and SITC 51454. As of Q4 2014, RASAGILINE MESYLATE remains US FDA's Preferred Term for this commodity. Rasagiline mesylate bears US NLM identifiers UMLS ID C1615645 and NCI Concept Code C66511. SMILES: CS(=O)(=O)O.C#CCN[C@@H]1CCC2C1CCCC2.

